Post Test and Evaluation

Please note that to receive credit you must achieve a score of at least 70%.
Credit will be uploaded to CPE Monitor within 4 weeks of successful completion of the activity.

Post-Activity Test

Question Title

1. The therapeutic target of epoprostenal is within the:

Endothelin pathway

Prostacyclin pathway

Glutathione pathway

Nitric oxide pathway

Question Title

2. Treprostinil is available in all of the following formulations except:

Oral

Intravenous

Subcutaneous

Inhaled

Question Title

3. The use of nitrates is contraindicated in patients receiving a phosphodiesterase type 5 (PDE-5) inhibitor.

True

False

Question Title

4. Pulmonary arterial hypertension is defined as having a mean pulmonary arterial pressure (mPAP) of:

>10 mmHg

>25 mmHg

>40 mmHg

>60 mmHg

Question Title

5. Current PAH therapy targets all of the following pathways except:

Vasoactive intestinal peptide (VIP)

Endothelin

Nitric Oxide

Prostacyclin